In a review of more than 2,000 people with confirmed Ebola cases in the Democratic Republic of Congo, researchers found case fatality was 27% among Ervebo patients and 56% among unvaccinated patients. The findings were published Feb. 7 in The Lancet Infectious Diseases.
The study is the first to research the retrospective efficacy of the Ebola vaccine, the researchers said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
